Category
Europe
Health technology assessment, pricing and access across Europe, including EU-level joint clinical assessment and the national systems that still decide funding. Coverage spans the major markets and the smaller systems that often move first.
686 articles in this topic.
Articles in this category
10/19/2026
Adverse reaction reports in Portugal rise with GLP-1 use
Infarmed has logged 695 suspected adverse reactions to GLP-1 drugs in Portugal since 2024, most linked to Mounjaro.
Read Article →
10/19/2026
Foundayo Oral GLP-1 Tablet Gets Positive EU Opinion
The EMA's CHMP has backed Foundayo, a once-daily orforglipron tablet, for weight management and type 2 diabetes.
Read Article →
10/19/2026
EMA Draft Reflection Paper Sets Rules for Confirmatory Platform Trials
"EMA's draft reflection paper sets out how confirmatory platform trials should handle controls, randomisation, blinding and multiplicity. Comments are due 31 January 2027. #SyenzaNews #MarketAccess #ClinicalTrials"
Read Article →
10/15/2026
AI guidance in clinical development: what industry is asking for
Regulators at the HMA-EMA AI group on 5 October 2026 outlined AI guidance in clinical development, with a concept paper and public consultation to follow.
Read Article →
10/15/2026
Social prescribing in Portugal: pilots, gaps and the cost of time
Social prescribing is not yet part of Portugal's national health system. Economists are asking whether it works, and who pays for it.
Read Article →
10/13/2026
Health Security in Europe: Why Resilience Starts Before a Crisis
Health security in Europe is being redefined from emergency response to national resilience, and the EFPIA View argues it starts with funded health systems.
Read Article →
10/13/2026
Individualised Genetic Therapies Test Regulation, Payment and HTA
OHE's A Dose of Economics explores why medicines made for one patient challenge regulation, payment and HTA.
Read Article →
10/12/2026
The Strategic Health Economy: Why Finance Ministries Still See Health as a Cost
At the World Health Summit in Berlin, speakers from the European Commission, Japan, Africa, the Asian Development Bank and industry argued that health is a strategic economic asset, and asked how to persuade finance ministries. #SyenzaNews #HealthEconomics
Read Article →
10/12/2026
AI in Medical Education: Responsible Integration Across the Training Continuum
AI is entering every stage of medical training. A new npj Digital Medicine Perspective maps how to integrate it responsibly across UGME, GME and CME.
Read Article →
10/9/2026
Multiple Sclerosis Health Utilities Decline With Disability
Health utilities for multiple sclerosis fall with disability, and progressive forms score lowest. A UK cohort of 5,772 patients gives modellers EQ-5D and cost inputs by MS type and EDSS band. #SyenzaNews #MarketAccess
Read Article →
10/9/2026
Clinical trial applications advice becomes permanent from 2027
The EU's ACT EU advice pilot for clinical trial applications becomes permanent in January 2027, with updated sponsor guidance.
Read Article →
10/9/2026
Uptake of New Cancer Medicines in Europe Still Varies
Uptake of new cancer medicines in Europe still varies, with a three-fold gap between countries in 2023.
Read Article →